Med tech M&A madness continues: Cooper to buy Sauflon for $1.2B

The Cooper Companies gained almost 6% in early trading after it said it would acquire British contact lens company Sauflon Pharmaceuticals. The Pleasanton, CA-based medical device company used offshore cash, in part, to finance the $1.2 billion deal.

AHRQ report highlights government concern over chronic wound care, home healthcare

The federal Agency for Healthcare Research and Quality said in a draft version of its recent technology assessment that it could not determine the safety and efficacy of negative pressure wound therapy (NPWT) technologies in home healthcare settings.

Report: $2.3B in digital health venture financing in the first half

Digital health funding company Rock Health, announced a successful mid-year report, and said the last 6 months saw a record-breaking $2.3 billion of funding between the 143 companies, more than the entire 2013 total. 

FDA clears 3D virtual reality device for surgical procedures

Surgical Theater scored FDA clearance for its 3D, augmented reality surgical navigation advanced platform (SNAP) for operating room procedures.

In obesity device race, ReShape lines up with FDA

There has been no new medical device to treat obesity approved by the FDA in more than a decade. A series of companies are hoping to be the first, including ReShape Medical, which has filed a PMA with FDA for its ReShape Integrated Dual Balloon System aimed at weight loss for the obese with a body mass index from 30 to 40.

Neuro-stimulator startup electroCore secures Series A expansion to $50M

Investors in migraine device startup electroCore has expanded its Series A round to $50 million. The company initially secured a $40 million tranched round in March 2013. The newly expanded financing comes just as the company prepares to submit its product to the FDA.

InSightec raising $50M Series D for ultrasound tumor treatment

GE-backed InSightec is in the process of raising a $50 million Series D round to fund its ultrasound tumor treatment technology. York Capital Management is investing and opening up the round to additional investors who could join the existing round or expand the total to $62.5 million. The company's pre-money valuation in this financing is $200 million.

Slimy MRSA streamers found to clog medical devices

A study of MRSA, a major cause of infections developed in hospitals, found that the bacteria form thin, slimy, thread-like structures, called streamers, effectively clogging up wherever it has taken up residence.

Study: One-third of knee replacements are inappropriate

For the first time, researchers have examined if knee replacement surgeries comply with criteria validating their appropriateness. They found that more than one-third of knee replacement surgeries in the U.S. were inappropriate using a patient classification system.

Stryker to buy Small Bone Innovations for up to $375M

Stryker will add the world's only PMA-approved, cementless, three-piece total ankle replacement system to its portfolio with its acquisition of Pennsylvania's Small Bone Innovations for up to $375 million in cash, the company announced June 30.

Device for 'smart' Kegel exercises to debut soon

Adult toy company Minna Life is accepting preorders on Kickstarter for its kGoal pelvic trainer device and app, which it claims is the world's first smart Kegel trainer.

Researchers develop a durable hydrogel for use with implantable devices

Researchers at Tohoku University in Japan have come up with a stretchable and durable electrode-hydrogel that could open the door for the development of new generations of wearable and implantable devices.

Nanotech implant to reverse blindness targeted for 2017

Bloomberg interviewed Israeli medical device incubator co-founder and CEO of Rainbow Medical, Efi Cohen-Arazi. He highlighted portfolio company Nano-Retina, which has an implant that the company says can restore vision to the blind patients with a stoppage or breakout of the retina.

Medtronic, Covidien chief integration officer talks about what the deal means

The leader of the looming integration effort facing Medtronic and Covidien stressed "balance sheet flexibility" as one of the main drivers of the $43 billion mega deal, and said it will lead to more M&A activity in early stage companies, although some investors disagree.

Implantable cardiac monitor better than standard stroke care, NEJM study finds

Continuous monitoring of stroke patients with an implantable monitor catches more potential problems than the standard, short-term cardiac monitoring. That's according to a study of the Reveal XT Insertable Cardiac Monitor (ICM) from Medtronic in a paper that was published recently in The New England Journal of Medicine.

Merz to buy Ulthera to strengthen beautification biz

About a year after it was outbid for skincare company Obagi by Valeant, Germany's Merz announced June 26 another play to to boost its aesthetics niche, this time involving devices. Merz is acquiring ultrasound company Ulthera, provider of the only nonsurgical, FDA-cleared treatment for facial skin tightening, for $600 million.

FDA clears first robotic exoskeleton for spinal cord injury patients

Argo Medical Technologies scored FDA clearance for the first robotic exoskeleton to help people with spinal cord injuries walk.

Vagus nerve stimulator effective to prevent migraines, study says

Startup electroCore demonstrated that its vagus nerve stimulator can prevent chronic migraine. The results of a small, sham-controlled study showed that the company's gammaCore device reduced the number of headache days per month and that those results improved over time.

Philips, to create clinical, cloud-based platform

Royal Philips and are partnering to build a cloud-based platform to advance clinical information sharing and patient engagement. The expectation is that Philips brings to the table its clinical strength with its established medical device, imaging and monitoring presence, while will contribute its cloud-computing software experience.

Report: Medtronic acquisition of Covidien to save $3.5B to $4.2B in taxes

Medtronic is stirring the U.S. tax pot with its announcement of an acquisition of Ireland-based company, Covidien. The acquisition would make Medtronic a foreign-based company, releasing it from U.S. tax laws and saving the company $3.5 to $4.2 billion annually.